CVRx  

9201 W. Broadway Ave.
Suite 650
- Minneapolis,  MN  55445

United States
http://www.cvrx.com/
  • Booth: 1401

CVRx, Inc. is a privately held company founded in 2001 and headquartered in Minneapolis. The company has developed the second generation Barostim neo, an implantable system designed to treat heart failure and hypertension (high blood pressure). Barostim neo has received CE marking for the treatment of heart failure. Barostim neo has also received CE marking for the treatment of hypertension. It is under clinical evaluation for the treatment of heart failure and hypertension in the United States.